Pyrazolo[3,4-d]pyrimidine compounds
US8637529B2 · kind B2 · utility
103Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2011 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Jul 25, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to novel compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are as defined herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, Crohn's disease, psoriasis and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.